References
- Breems D A, Van Putten W LJ, Huijgens P C, Ossenkoppele G J, Verhoef G EG, et al. Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse. J Clin Oncol 2005; 23: 1969–1978
- Giles F, Verstovsek S, Garcia-Manero G, Thomas D, Ravandi F, Wierda W, et al. Validation of the European Prognostic Index for younger adult patients with acute myeloid leukaemia in first relapse. Br J Haematol 2006; 134: 58–60
- Medeiros B, Minden M, Schuh A, Schimmer A, Yee K, Lipton J, et al. Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years). J Leuk Lymphoma 2007; 48: 65–71
- Smith S M, Le Beau M M, Huo D, Karrison T, Sobecks R M, Anastasi J, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 2003; 102: 43–52
- Pedersen-Bjergaard J, Rowley J. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 1994; 83: 2780–2786
- Kelaidi C, Ades L, Chevret S, Sanz M A, Guerci A, Thomas X, et al. Late Relapses in APL Treated with ATRA and Anthracycline Based Chemotherapy: The European APL Group Experience (APL 91 and APL 93 Trials). Blood (Suppl) 2005; 106: 890
- Bench A J, Erber W N, Scott M A. Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders. Clin Lab Haematol 2005; 27: 148–171
- Tsukamoto N, Karasawa M, Tanaka Y, Yokohama A, Uchiumi H, Matsushima T, et al. Recurrence of acute myelogenous leukemia with the same AML1/ETO breakpoint as at diagnosis after complete remission lasting 15 years: analysis of stored bone marrow smears. Int J Hematol 2003; 78: 362–369
- Mrozek K, Marcucci G, Paschka P, Whitman S P, Bloomfield C D. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?. Blood 2006, blood-2006-06-001149
- Konrad M, Metzler M, Panzer S, Ostreicher I, Peham M, Repp R, Haas O A, Gadner H, Panzer-Grumayer E R. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone. Blood 2003; 101: 3635–3640
- Bhojwani D, Kang H, Moskowitz N P, Min D J, Lee H, Potter J W, et al. Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. Blood 2006; 108: 711–717